Morgan Paull

Morgan Paull started their career as a Congressional Page in the U.S. House of Representatives in 2007. They then worked as an Intern in the United States Senate in 2009. They later gained research experience as an Undergraduate Researcher at both the Joint BioEnergy Institute from June to August 2011 and the Wyss Institute for Biologically Inspired Engineering from September 2011 to April 2013. In 2013, they worked as a Bioinformatics Research Assistant at the Harvard School of Public Health for two months. They then co-founded Mendo, Inc in August 2016, a microfluidic liquid-handling company that develops handheld molecular assay devices. Their entrepreneurial venture lasted until March 2020. From March 2018 to March 2020, they worked as a Consultant at McKinsey & Company. In 2020, they joined BridgeBio as the VP of Business Development & Operations, and in 2021, they joined QED Therapeutics as the VP of Strategy and Operations.

Morgan Paull has a Bachelor of Science (B.S.) in Engineering Science from Harvard University. They also have a Master of Science (M.S.) in Bioengineering from Stanford University and a Master of Science (MS) in Management Science and Engineering, also from Stanford University.